1Gilson AM, Joranson DE, Maurer MA, Improving State Medical Board Policies: Influence of a Model[J]. J Law Med Eth, 2003, 31: 119-129.
2Passik SD. Letter to the editor: Responding rationally to recent reports of abuse/diversion of Oxycontin[J]. J Pain Sympt Manage ,2001 ;21:359-360.
3WHO, Medical need for opioid analgesics. In: WHO, ed.Achieving balance in national opioids control policy: Guidelines for Assessment[M]. Geneva: WHO , 2000, 3-4.
4Yadgood MC, Miller PJ, Mathews PA. Relieving the agony of the new pain management standards[J]. Ant J Hosp Palliat Care ,2000,17:333-341.
5Yu SY, Wang XS, Chen Y, et al. Special aspects of cancer pain management in a Chinese general hospital[J]. Eur J Pain , 2001,5:15-20.
6Wang XS, Li TD, Yu SY, et al . Status of pain and palliative care[J]. J Pain and Sympt Manage , 2002, 24: 177-179.
7Joranson DE, Ryan KM, Gilson AM, et al .Trends in Medical Use and Abuse of Opioid Analgesics[J]. JAMA , 2000,283 : 1710-1714.
8Bleeker CP, Bremer RC, Dongelmans DA, et al . Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report[J]. Eur J Pain, 2001,5:325-329.
9Mystakidou K, Befon S, Tsilika E, et al . Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids[J].Oncology , 2002,62:9-16.
10Twycross R, Wilcock A. Symptom Manage of Advaned Cancer. 3rd ed[M]. Oxon: Radcliffe Medical Press , 2002. 17-68.
